Table 1 Prevalence of pHR and HR HPV genotypes and pairs according to histological results
Histological results | ||||
|---|---|---|---|---|
HPV Genotype | < CIN 2 (n = 44) | CIN 2 (n = 12) | CIN 3 (n = 18) | ICC |
HPV 16 | 32% (14/44) | 25% (3/12) | 44%(8/18) | |
HPV 53 | 25% (11/44) | 17% (2/12) | 28% (5/18) | 1 |
HPV 52 | 16% (7/44) | 42% (5/12) | 17% (3/18) | |
HPV 56 | 18% (8/44) | 8% (1/12) | 33% (6/18) | |
HPV 58 | 16% (7/44) | 42% (5/12) | 6% (1/18) | |
HPV 18 | 16% (7/44) | 25% (3/12) | 17% (3/18) | |
HPV 35 | 14% (6/44) | 25% (3/12) | 18% (4/18) | |
HPV 31 | 7% (3/44) | 33% (4/12) | 18% (4/18) | |
HPV 33 | 7% (4/44) | 25% (3/12) | 28% (5/18) | |
HPV 39 | 7% (3/44) | 17% (2/12) | 17% (3/18) | |
HPV 45 | 0% | 8% (1/12) | 11% (2/18) | |
HPV 59 | 2% (1/44) | 8% (1/12) | 11% (2/18) | |
HPV 66 | 20% (9/44) | 8% (1/12) | 9% (1/18) | |
HPV 68 | 7% (3/44) | 0% (0/12) | 9% (1/18) | |
Multiple HPV coinfection | 60% (26/44) | 83% (10/12) | 67% (12/18) | |